PSP Vendor RFP Checklist for Pharmaceutical Companies in Saudi Arabia
A structured RFP checklist for evaluating patient support program vendors in Saudi Arabia: compliance, data residency, workflow fit, integration, TCO.
Key takeaways
- A Saudi patient support program RFP should score vendors across eight distinct pillars to prevent low-cost bids from compromising on compliance, data residency, or scalability.
- Commercial negotiations must remain strictly separate from mandatory clinical, privacy, and safety gates, and weighted evaluation scores should never override mandatory requirements.
- Medical Affairs should actively participate in vendor evaluation alongside Procurement because clinical workflow alignment and adverse event intake require clinical rather than commercial judgment.
Reviewed by the CareSync Medical Team · Last reviewed
On this page
A patient support program (PSP) RFP in Saudi Arabia should score vendors across eight pillars: regulatory and compliance alignment, data residency, clinical workflow fit, multi-program scalability, integration capability, Arabic/English localization, reporting, and commercial terms. Scoring each pillar separately — instead of comparing a single blended price — is what prevents a low-cost vendor from winning on price while failing on compliance or scale.
Evidence to request before signing
For each scored pillar, record the evidence reviewed, the person who reviewed it, any open dependency and the contractual acceptance criterion. Use a non-identifiable demonstration case to trace referral, consent, educator assignment and a safety handoff. Test permissions with different roles rather than relying on screenshots. Ask for a deployment-specific hosting and subprocessor description, data export arrangements and support ownership. Treat an unverified capability as an open question, not a passed score. Keep commercial negotiation separate from the documented clinical, privacy and safety gates; a weighted score should never override a mandatory requirement.
Why a structured RFP matters in KSA
PSP vendor selection in Saudi Arabia carries more regulatory weight than a typical SaaS procurement: patient data residency, SFDA-aligned pharmacovigilance workflows, and PDPL obligations all sit inside the evaluation. An unstructured RFP — one built around a generic feature checklist — tends to under-weight these factors because they don't show up as visibly as UI screenshots or demo polish. A structured scoring rubric forces compliance, scalability, and support model into the same conversation as price.
The 8 RFP evaluation pillars
| # | Pillar | What to probe |
|---|---|---|
| 1 | Regulatory & compliance alignment | How the platform's workflows are designed to support SFDA pharmacovigilance timelines and PDPL data principles — ask for specifics, not a compliance claim alone |
| 2 | Data residency & security | Where data is hosted, encryption standards, access controls, breach-notification process |
| 3 | Clinical & operational workflow fit | Nurse visit scheduling, follow-up documentation, AE intake — does it match how your field team actually works today |
| 4 | Multi-program scalability | Can a second or third brand/therapy area be added without a re-platform |
| 5 | Integration capability | CRM, ERP, pharmacy, and call-center integration — native connectors vs. custom development |
| 6 | Arabic/English localization | Full bilingual UI and documentation, not a translated front-end over an English-only data model |
| 7 | Reporting & KPI dashboards | Real-time enrollment, adherence, and operational KPIs vs. manual export-and-build reporting |
| 8 | Vendor track record & commercial terms | Implementation timeline, support SLAs, reference checks, total cost of ownership over the contract term |
Sample RFP scoring matrix
| Pillar | Weight | Vendor score (1–5) | Notes |
|---|---|---|---|
| Regulatory & compliance alignment | High | ||
| Data residency & security | High | ||
| Clinical & operational workflow fit | High | ||
| Multi-program scalability | Medium | ||
| Integration capability | Medium | ||
| Arabic/English localization | Medium | ||
| Reporting & KPI dashboards | Medium | ||
| Vendor track record & commercial terms | High |
Weight each pillar before scoring vendors, not after — agreeing weights up front across PSP, Market Access, and Procurement stakeholders is what keeps the final decision defensible.
Red flags to watch for in vendor responses
- Compliance claims with no specifics on how SFDA or PDPL-aligned workflows are actually implemented
- "Custom development" quoted for core features like AE reporting or Arabic localization — ask whether these are included, configured or separately developed, and assess the implications
- No clear answer on where patient data is physically hosted
- Reference clients who can't speak to a comparable scope (patient volume, therapy area, multi-brand use)
- A single blended price with no breakdown by the cost components in your scope document
FAQ
How many vendors should a PSP RFP shortlist include?
Enough to compare approaches without diluting evaluation effort — set shortlist size to fit your procurement process, scope and available evaluation capacity.
Should Medical Affairs be involved in vendor scoring, not just Procurement?
Yes. Clinical workflow fit and AE reporting design are clinical judgments, not commercial ones — scoring without Medical Affairs input risks selecting a vendor that is cheap but operationally wrong for your program.
What's the difference between an RFP and an RFI for PSP vendors?
An RFI (request for information) gathers capability information before scope is finalized; an RFP (request for proposal) asks for binding commercial and implementation terms against a defined scope — use the 8-pillar framework above for both, scored more lightly at RFI stage.
Applying this framework to CareSync PSP Connect
CareSync PSP Connect supports modular discussions around enrollment, consent, educator follow-up, adherence support and tracked safety handoffs. Confirm the proposed configuration, hosting, access controls, integrations and reporting cadence with the implementation team. This article is a buyer framework, not a promise that every requested function is included or already deployed. Screens and cover dashboards are illustrative, not patient data or measured customer results. Clinical and pharmacovigilance decisions remain with the responsible professionals.
Related PSP buyer guides
Sources and scope
This is an editorial procurement framework, not a clinical study, market-price survey or validated outcomes model. Use current official guidance for applicable obligations.
Prepared by the CareSync Medical Team. This article is educational, not medical advice or a substitute for clinical, legal or regulatory review. Research findings are source-specific, not measured CareSync outcomes.